Company · Healthtech & Bio

Integra Therapeutics

integra-tx.com ↗ ·Barcelona ·Other

Barcelona-based biotech developing next-generation gene writing tools for advanced therapies, including its flagship FiCAT platform combining CRISPR-Cas precision with engineered piggyBac transposase gene-transfer efficiency. Founded in 2020 as a spin-off of Universitat Pompeu Fabra (UPF), it targets gene therapies for rare diseases and cell therapies (e.g. CAR-T) for oncology and autoimmune disease. Has raised roughly $22.9M across seed and pre-Series A rounds, most recently a €10.7M round in September/October 2025.

Founded

2020

Founders

News

Rounds

Investors

SectorsGene Editing, Gene Therapy, Cell Therapy, Biotechnology Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Profile updated 2 Aug 2026

Founders

Avencia Sánchez-Mejías

Co-founder & Chief Executive Officer

Marc Güell

Co-founder & Chief Scientific Officer

Global models

No comparables on record yet.

Investors 7

AdBio Partners

adbio.partners ↗

Investor France

Advent France Biotechnology

Investor France

Columbus Venture Partners

Takeda Ventures

www.takedaventures.com ↗

Investor Japan

Funding rounds 4

Seed · €10.7M

Integra Therapeutics, a Pompeu Fabra University spin-off developing the FiCAT gene-writing platform, closed a €10.7 million pre-Series A rou…

2025-09-08

Other · €10.5M

Integra Therapeutics, a Pompeu Fabra University spin-off developing the FiCAT gene-writing platform, was awarded up to €10.5 million by the …

2024-07-17

Seed · €1.5M

Integra Therapeutics, a Universitat Pompeu Fabra spin-off developing the FiCAT gene-writing platform, closed a new €1.5 million investment l…

2022-03-29

Seed · €4.5M

Integra Tx is a Pompeu Fabra University spin-off developing next-generation gene-writing tools. It closed a €4.5M first round led by Advent …

2021-12-02

News & media 8

Published	Article
2025-10-02	Generative AI is more efficient than nature at designing proteins to edit the genome ↗ EurekAlert!
2025-09-08	Integra Therapeutics raises €10.7M to advance FiCAT platform and CAR-T validation ↗ Tech.eu
2025-05-14	Integra Therapeutics Presents CAR-T Cell Data at ASGCT 2025 ↗ BioPharm International
2025-02-24	Integra Therapeutics, first company to move into Advanced Therapies Platform at SJD Barcelona Children's Hospital ↗ BioSpace
2024-11-04	Spanish gene editing biotech licenses DNA-cutting enzymes from Caszyme for up to $43M ↗ FierceBiotech
2024-07-17	Integra Therapeutics receives EIC Accelerator funds of up to €10.5M for gene writing tools ↗ Tech.eu
2023-03-30	Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy ↗ BioSpace
2021-12-02	Barcelona-based biotechnology startup Integra Tx gets €4.5 million funding injection ↗ EU-Startups